Literature DB >> 9258345

Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity.

D V Faller1, H Weng, D T Graves, S Y Choi.   

Abstract

Moloney murine leukemia virus (Mo-MuLV) is a thymotropic and leukemogenic retrovirus which causes T lymphomas. Recently, Mo-MuLV has been shown to trans-activate cellular genes. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine which can promote the migration and diapedesis of monocytes and lymphocytes, as well as inducing metastasis of lymphomas. Here we demonstrate that introduction of Mo-MuLV or the MuLV LTR alone, transiently or stably, into Balb/c-3T3 cells or HeLa cells resulted in 9-11 fold increases in MCP-1 transcripts. This trans-activation of the MCP-1 gene by the Mo-MuLV LTR is independent of the physical location of the MCP-1 gene or of the LTR, occurring whether the LTR or the MCP-1 gene is integrated in the genome or transiently expressed. Immunoblot analysis using an anti-MCP-1 polyclonal antibody showed that the expression of the MuLV LTR in HeLa cells also induced the appearance of the MCP-1 protein. Boyden Chamber analysis demonstrated that the MCP-1 chemotactic activity produced by HeLa cells with an integrated MuLV LTR was elevated by 11 fold and that neutralizing antibody to human MCP-1 abrogated monocyte migration in response to MuLV LTR expression. Promoter deletional analysis showed the LTR responsive cis-acting element in the MCP-1 promoter is located between -141 and -88. Deletion of this region abolished the trans-activation of MCP-1 by the LTR. These LTR-mediated activations of a chemotactic and inflammatory cytokine may be relevant as mechanisms whereby retroviruses which do not contain oncogenes can induce neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258345     DOI: 10.1002/(SICI)1097-4652(199708)172:2<240::AID-JCP11>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.

Authors:  S K Ghosh; P Roy-Burman; D V Faller
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.

Authors:  H Y Dai; G I Troseth; M Gunleksrud; T Bruland; L A Solberg; H Aarset; L I Kristiansen; A Dalen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.

Authors:  S P Lim; A Garzino-Demo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

5.  Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

Authors:  S K Ghosh; D V Faller
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Authors:  Lora W Forman; Ruma Pal-Ghosh; Remco A Spanjaard; Douglas V Faller; Sajal K Ghosh
Journal:  FEBS Lett       Date:  2009-03-29       Impact factor: 4.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.